Evaluating the progression of Friedreich ataxia and its treatment


Friedreich ataxia is characterised by slowly progressive neurodegeneration and cardiomyopathy. Currently, no treatments have been proven to delay, prevent, or reverse the inexorable decline that occurs in this condition; however, several pharmaceutical agents are undergoing clinical assessment. Because initial beneficial therapies are likely to slow disease… (More)
DOI: 10.1007/s00415-009-1007-y


2 Figures and Tables